← All organizations

The Mind Research Network

Academic/HospitalWebsite ↗

Also known as: Director, Neurogenetics Core, The Mind Research Network | Mind Research Network | The Mind Research Network

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 31, 2023

Timeline

1990s

Jan 1, 1998
The Mind Research Network— Founded

Drugs by trial phase (11 distinct, 12 trials)

Phase 4 (1 own, 0 via acquisition)

varenicline

Phase 3 (1 own, 0 via acquisition)

olanzapine

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

tetrahydrocannabinol

Other trials (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (23)

NCT06036511CollaboratorPhase 1/Phase 2Dec 31, 2023
NCT04396834Lead sponsorPhase 2Dec 4, 2019
NCT04396834Overall official - principal investigatorPhase 2Dec 4, 2019
NCT04396847Lead sponsorPhase 2Oct 25, 2019
NCT04396847Overall official - principal investigatorPhase 2Oct 25, 2019
NCT03539432Lead sponsorPhase 2May 16, 2018
NCT03424681Overall official - principal investigatorPhase 2Dec 11, 2017
NCT03424681Reponsible party - principal investigatorPhase 2Dec 11, 2017
NCT03424681Lead sponsorPhase 2Dec 11, 2017
NCT03191084CollaboratorEarly Phase 1Dec 1, 2017
NCT02757313CollaboratorN/AOct 1, 2016
NCT02534454Lead sponsorN/AAug 1, 2015
NCT03037749CollaboratorN/AMar 1, 2015
NCT03037749Overall official - principal investigatorN/AMar 1, 2015
NCT01228175Overall official - principal investigatorPhase 4Mar 1, 2010

Details

Founded: Albuquerque, NM, US Jan 1, 1998
Last known activity: Dec 31, 2023